Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.
Ganz PA, Bandos H, Španić T, Friedman S, Müller V, Kuemmel S, Delaloge S, Brain E, Toi M, Yamauchi H, de Dueñas EM, Armstrong A, Im SA, Song CG, Zheng H, Sarosiek T, Sharma P, Geng C, Fu P, Rhiem K, Frauchiger-Heuer H, Wimberger P, t'Kint de Roodenbeke D, Liao N, Goodwin A, Chakiba-Brugère C, Friedlander M, Lee KS, Giacchetti S, Takano T, Henao-Carrasco F, Virani S, Valdes-Albini F, Domchek SM, Bane C, McCarron EC, Mita M, Rossi G, Rastogi P, Fielding A, Gelber RD, Scheepers ED, Cameron D, Garber J, Geyer CE, Tutt ANJ. Ganz PA, et al. Among authors: giacchetti s. J Clin Oncol. 2024 Apr 10;42(11):1288-1300. doi: 10.1200/JCO.23.01214. Epub 2024 Feb 1. J Clin Oncol. 2024. PMID: 38301187 Free PMC article. Clinical Trial.
Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-Fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer.
Gholam D, Giacchetti S, Brézault-Bonnet C, Bouchahda M, Hauteville D, Adam R, Ducot B, Ghémard O, Kustlinger F, Jasmin C, Lévi F. Gholam D, et al. Among authors: giacchetti s. Oncologist. 2006 Nov-Dec;11(10):1072-80. doi: 10.1634/theoncologist.11-10-1072. Oncologist. 2006. PMID: 17110626 Free article. Clinical Trial.
Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15.
Lehmann-Che J, Hamy AS, Porcher R, Barritault M, Bouhidel F, Habuellelah H, Leman-Detours S, de Roquancourt A, Cahen-Doidy L, Bourstyn E, de Cremoux P, de Bazelaire C, Albiter M, Giacchetti S, Cuvier C, Janin A, Espié M, de Thé H, Bertheau P. Lehmann-Che J, et al. Among authors: giacchetti s. Breast Cancer Res. 2013 May 11;15(3):R37. doi: 10.1186/bcr3421. Breast Cancer Res. 2013. PMID: 23663520 Free PMC article.
[Nausea and vomiting in chemotherapy].
Giacchetti S, Imbeaux PH, Alby N, Aguerri MF. Giacchetti S, et al. Rev Infirm. 1992 Feb;42(4):63-5. Rev Infirm. 1992. PMID: 1316631 French. No abstract available.
Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches.
Lehmann-Che J, Amira-Bouhidel F, Turpin E, Antoine M, Soliman H, Legres L, Bocquet C, Bernoud R, Flandre E, Varna M, de Roquancourt A, Plassa LF, Giacchetti S, Espié M, de Bazelaire C, Cahen-Doidy L, Bourstyn E, Janin A, de Thé H, Bertheau P. Lehmann-Che J, et al. Among authors: giacchetti s. Br J Cancer. 2011 May 24;104(11):1739-46. doi: 10.1038/bjc.2011.135. Epub 2011 May 3. Br J Cancer. 2011. PMID: 21540864 Free PMC article.
[Primary pseudo-ovarian peritoneal carcinosis. 4 cases].
Colbert N, Izrael V, Raoul Y, Giacchetti S, Favre M, Bazelly B, Laugier A, Schlienger M, Loygue J. Colbert N, et al. Among authors: giacchetti s. Presse Med. 1985 Mar 30;14(13):725-7. Presse Med. 1985. PMID: 3157974 French.
The evolving role of PET/CT in breast cancer.
Groheux D, Giacchetti S, Rubello D, Al-Nahhas A, Moretti JL, Espié M, Hindié E. Groheux D, et al. Among authors: giacchetti s. Nucl Med Commun. 2010 Apr;31(4):271-3. doi: 10.1097/MNM.0b013e3283354cb4. Nucl Med Commun. 2010. PMID: 20375973 No abstract available.
117 results